MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1089/thy.2025.0017

Медицинская библиотека · Thyroid : official journal of the American Thyroid Association · 2025

First Report of SPECC1L::ALK Fusion in Medullary Thyroid Carcinoma with Remarkable Response to Alectinib.

Bischoff Hervé, Fattori Antonin, Moinard-Butot Fabien, Schneegans Olivier, Diaz Pablo, Reita Damien, Rimelen Valérie, Voegeli Anne-Claire, Bender Laura

СтатьяКлинический случайПеревод в очереди

Аннотация

Background

Rearrangements of the ALK gene are rare in medullary thyroid carcinoma (MTC), with limited data on the efficacy of ALK inhibitors in this context. Novel fusions, such as SPECC1L::ALK, have not been extensively studied.

Methods

We present a case of a 33-year-old woman with metastatic MTC, in whom molecular profiling using next-generation sequencing (Archer FusionPlex®) identified a SPECC1L::ALK gene fusion. Treatment with the ALK inhibitor alectinib was initiated at 600 mg twice daily.

Results

The patient demonstrated a dramatic partial to near-complete response after 6 days of treatment, as shown by positron emission tomography-computed tomography. At 6 weeks, a complete response was confirmed. Treatment was generally well tolerated, aside from grade 3 myalgia with elevated creatine phosphokinase, managed with temporary cessation and dose adjustment. As of the latest follow-up (8 months), the patient remains on alectinib with sustained complete response.

Conclusions

This is the first report of a SPECC1L::ALK fusion in MTC. The dramatic response to alectinib highlights the importance of molecular profiling and suggests that ALK inhibitors may benefit patients with rare ALK fusions in thyroid cancers.

Для цитирования: Bischoff Hervé, Fattori Antonin, Moinard-Butot Fabien, Schneegans Olivier, Diaz Pablo, Reita Damien, Rimelen Valérie, Voegeli Anne-Claire, Bender Laura. First Report of SPECC1L::ALK Fusion in Medullary Thyroid Carcinoma with Remarkable Response to Alectinib.. Thyroid : official journal of the American Thyroid Association. 2025. DOI: 10.1089/thy.2025.0017.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.